Navigation Links
Keryx Biopharmaceuticals to Present at the Jefferies & Co. Healthcare Conference
Date:6/24/2008

Presentation Scheduled for Thursday, June 26th at 2:30pm ET

NEW YORK, June 24 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that Michael S. Weiss, the Company's Chairman and Chief Executive Officer, is scheduled to present at the Jefferies & Co. Healthcare Conference being held in New York City.

Mr. Weiss' presentation will be webcast live on Thursday, June 26th at 2:30pm ET and will be accessible from the Investor Information page of the Company's Website at http://investors.keryx.com. An archived version of the webcast will be available following the conclusion of the live presentation.

ABOUT KERYX BIOPHARMACEUTICALS, INC.

Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including renal disease and cancer. Keryx is developing Zerenex(TM) (ferric citrate), an oral, iron-based compound that has the capacity to bind to phosphate and form non-absorbable complexes. Zerenex is currently in Phase 2 clinical development for the treatment of hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal disease, or ESRD. The Company is also developing KRX-0401 (perifosine), a novel, potentially first-in-class, oral anti-cancer agent that modulates Akt, a protein in the body associated with tumor survival and growth. KRX-0401 also modulates a number of other key signal transduction pathways, including the JNK and MAPK pathways, which are pathways associated with programmed cell death, cell growth, cell differentiation and cell survival. KRX-0401 is currently in Ph
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2008 Financial Results
2. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on First Quarter 2008 Financial Results on Monday, May 12, at 8:30 A.M. EDT
3. Keryx Biopharmaceuticals to Present at the Deutsche Bank 33rd Annual Health Care Conference
4. Keryx Biopharmaceuticals Receives Nasdaq Notification
5. Keryx Biopharmaceuticals Announces Implementation of Strategic Restructuring Plan
6. Keryx Biopharmaceuticals to Present at the Cowen and Company 28th Annual Health Care Conference
7. Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint
8. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2007 Financial Results
9. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Fourth Quarter and Year-End 2007 Financial Results on Monday, February 25, at 8:30 A.M. EST
10. Keryx Biopharmaceuticals Announces Additions to Management Team
11. Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... , May 28, 2015  Quest Diagnostics Incorporated ... diagnostic information services, announced that it is scheduled to ... New York.  Steve Rusckowski , the company,s President ... five point strategy.  The presentation is scheduled for Tuesday, ... The presentation will be webcast live during the ...
(Date:5/28/2015)... Research and Markets( http://www.researchandmarkets.com/research/26qndf/nanobiotechnology ) ... new report "Nanobiotechnology Applications, Markets and ... An increasing use of nanobiotechnology by the ... will be applied at all stages of ... delivery to diagnostic applications in clinical trials. ...
(Date:5/28/2015)... May 27, 2015 Research and Markets( ... PharmaBiotech,s new report "Cell Therapy - Technologies, ... This report describes and evaluates cell therapy ... play an important role in the practice of ... old fashioned bone marrow transplants. Role of cells ...
(Date:5/28/2015)... Muncie, IN (PRWEB) May 28, 2015 The ... annual National Model Aviation Day on August 15, 2015. National ... model aviation nation-wide and to introduce model flying to the ... approximately 2,350 chartered clubs to participate in the celebration by ... have registered to host National Model Aviation Day events. ...
Breaking Biology Technology:Quest Diagnostics to Speak at the Jefferies 2015 Global Healthcare Conference 2Global Nanobiotechnology Market 2015-2024 - Applications, Markets and Companies 2Global Nanobiotechnology Market 2015-2024 - Applications, Markets and Companies 3Global Cell Therapy Market 2015-2020 - Technologies, Markets and Companies 2Model flying pilots celebrate the Academy of Model Aeronautics Foundation’s Third Annual National Model Aviation Day 2
... FDA Submission for Removal of Clinical Hold, ... Bulletin Board: GNTA) announced that the Company has,received ... the European,Patent Office for its pipeline product, tesetaxel, ... of matter for the tesetaxel drug,substance and to ...
... Technology to Lexicon Targets, COPENHAGEN, June 10 ... Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ) aimed,at ... for highly,validated drug targets., Under the terms ... will be applied to identify novel small molecule,lead ...
... Mass., June 9 Boston Scientific,Corporation (NYSE: ... Ratings,that it has revised its Rating Outlook on ... the Company,s long-term credit rating of,BB+., Fitch ... progress Boston,Scientific is making toward stabilizing its drug-eluting ...
Cached Biology Technology:Genta Receives Notice of Allowances for European Patents Related to Composition and Processes for Tesetaxel, a Leading Oral Taxane 2Genta Receives Notice of Allowances for European Patents Related to Composition and Processes for Tesetaxel, a Leading Oral Taxane 3Genta Receives Notice of Allowances for European Patents Related to Composition and Processes for Tesetaxel, a Leading Oral Taxane 4Nuevolution Announces Drug Discovery Alliance With Lexicon Pharmaceuticals 2Nuevolution Announces Drug Discovery Alliance With Lexicon Pharmaceuticals 3Boston Scientific Welcomes Revised Outlook From Fitch Ratings 2Boston Scientific Welcomes Revised Outlook From Fitch Ratings 3
(Date:5/8/2015)... Calif. , May 8, 2015 Synaptics Inc. ... solutions, today announced that members of the executive management team ... Morgan 43rd Annual Technology, Media and Telecom Conference Date: ... Hotel in Boston, MA ... 27, 2015 Time: 2:45pm ET Location: The New York Palace ...
(Date:4/27/2015)... , Apr. 27, 2015 NXT-ID, Inc. ... biometric authentication company focused on the growing mobile commerce ... shipping to pre-order customers the first week of May, ... the month of May. Gino ... significant milestone for the company as Wocket® enters the ...
(Date:4/17/2015)... BURNABY, Canada , April 17, 2015 /PRNewswire/ ... projects, growing security concerns, and technological advancement to ... Arabia until 2020   ... " Saudi Arabia Biometric Systems Market Forecast &  Opportunities, 2020 ", biometric ... is projected to register growth at CAGR ...
Breaking Biology News(10 mins):Synaptics to Present at Upcoming Investor Conferences 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3
... - With infections increasingly resistant to even the most ... Institute at Harbor-UCLA Medical Center (LA BioMed) report in ... clues they have uncovered in immune system molecules that ... Nannette Y. Yount present evidence that small proteins in ...
... prove a permanent turn on for some genes. Research published today ... why former smokers are still more susceptible to lung cancer than ... by Wan L Lam and Stephen Lam from the BC Cancer ... smokers, as well as from non-smokers who have never smoked. They ...
... AK The historic collaboration between leading scientists and ... for Health and the ,Global Environment at Harvard Medical ... continues this week with a trip to Alaska. A ... traveling together on August 25th to observe first- ,hand ...
Cached Biology News:Researchers discover new strategies for antibiotic resistance 2Smoking turns on genes -- permanently 2Scientist-evangelical Alaska expedition 2
...
... 48° Fixed Angle Polypropylene Rotor designed ... IEC Centra CL3/CL3R** and Centra-MP4/MP4R*. A ... operation. /MP4, ,EXCLUSIVE polypropylene rotor design ... be repeatedly autoclaved. Polypropylene rotors ...
... The Xcise is a powerful technology platform ... proteome analysis. High quality sample preparation ... user. , The Xcise is a powerful ... high throughput proteome analysis. It combines the ...
Request Info...
Biology Products: